Chinook Therapeutics CVR
13F holders, Q3 2025 (September 30)2holders −2
0new positions
2sold out
$0.00avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Chinook Therapeutics CVR in their 13F filings, down 2 from Q2 2025. 0 opened new positions and 2 sold out. The largest holders were Rhumbline Advisers ($0) and ORG Partners LLC ($0).
- Company
- Chinook Therapeutics CVR
- CUSIP
- 169CVR016
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $3K |
All 13F filers, Q2 2025 → Q3 2025: 80,363 shares sold, net −80,363 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 87,704 | $0 |
| ORG Partners LLC | 0.00% | No change | 30 | $0 |
"% of holder's portfolio" is CHINOOK THERAPEUTICS CVR's weight in each manager's 13F, not the share of Chinook Therapeutics CVR the manager owns.